The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors - a preliminary study.

Introduction: The outcome of Helicobacter pylori (Hp) eradication therapy from the aspect of prevention of chest pain recurrence is still uncertain. The aim of this study was to assess the influence of Hp eradication therapy on the risk of hospitalization due to acute coronary syndrome.Material and...

Descripción completa

Detalles Bibliográficos
Publicado en:Archives of Medical Science Vol. 7; no. 1; pp. 73 - 81
Autores principales: Budzynski, Jacek, Budzyński, Jacek
Formato: research tables/charts Journal Article
Publicado: Termedia Publishing House 2011 Feb
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108224303&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108224303
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17341922
        77TB
      jtl: Archives of Medical Science
      issn: 17341922
      maglogo: N
    pubinfo:
      dt: 2011 Feb
      vid: 7
      iid: 1
      pid: 24295
      pub: Termedia Publishing House
      place: , <Blank>
    artinfo:
      ui:
        108224303
        108224303
        NLM22291736
        2011342690
        10.5114/aoms.2011.20607
        NLM22291736
        PMC3258683
        108224303
      ppf: 73
      ppct: 8
      formats:
      tig:
        atl: The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors - a preliminary study.
      aug:
        au:
          Budzynski, Jacek
          Budzyński, Jacek
        affil: Department of Gastroenterology, Vascular Diseases and Internal Medicine, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland
      sug:
        subj:
          Angina Pectoris
          Coronary Disease Prevention and Control
          Gastroesophageal Reflux Prevention and Control
          Helicobacter Infections Therapy
          Metabolic Syndrome X Prevention and Control
          Adult
          Angiography
          Biopsy
          Chi Square Test
          Cox Proportional Hazards Model
          Data Analysis Software
          Descriptive Statistics
          Drug Resistance
          Electrocardiography
          Equipment and Supplies
          Female
          Fisher's Exact Test
          Funding Source
          Human
          Kaplan-Meier Estimator
          Male
          Middle Age
          Multivariate Analysis
          Poland
          Proton Pump Inhibitors
          Sex Factors
          T-Tests
          Wilcoxon Rank Sum Test
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Introduction: The outcome of Helicobacter pylori (Hp) eradication therapy from the aspect of prevention of chest pain recurrence is still uncertain. The aim of this study was to assess the influence of Hp eradication therapy on the risk of hospitalization due to acute coronary syndrome.Material and Methods: The analysis was carried out in 63 consecutive patients with recurrent retrosternal symptoms: 28 (44%) with significant coronary artery narrowing in coronarography not qualified for revascularization by an invasive cardiologist, and 35 (56%) with no obstructive coronary artery lesions. In 33 (52%) of the patients, Hp infection was found and standard eradication therapy with omeprazole (2 × 20 mg), amoxicillin (2 × 1 g) and metronidazole (2 × 500 mg) was recommended. The mean follow-up period was 977 ±249 days.Results: Chest pain requiring hospitalization because of unstable angina within the follow-up period was observed in 9 (27%) of the Hp-infected individuals and in 15 (50%) subjects in whom a urease test and histology did not confirm this infection (p = 0.055). The recommendation of Hp-eradication treatment was a significant factor prolonging the hospitalization-free period, both in the two Kaplan-Meier curve analyses (Cox's F test = 1.96; p = 0.049) and the Cox proportional hazard model (beta = -1.18; p = 0.045), but was weaker than the effect of the non-obstructive coronary angiogram (beta = -1.45; p = 0.03).Conclusions: The recommendation of Hp-eradication therapy may prolong the hospitalization-free period for patients with recurrent chest pain.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N